Aptitude Health

Register now for the Global Leukemia Academy’s next virtual meeting https://globalleukemiaacademy.com/meeting-21/. This session will offer a comprehensive overview of the latest clinical updates and novel treatment strategies for acute focused on the Asia-Pacific region.

Sign up here https://www.aptitudehealth.com/oncology-news/ to receive Aptitude Health’s monthly HemOnc Bulletin that includes industry insights, medical advances, expert perspectives, and other related news.

Researchers continue to support use of therapies, reporting that the benefits still outweigh the risks despite increase in events

Risk for Myeloid Neoplasms After CAR T-Cell Therapy - Aptitude Health Analyses show risk of myeloid neoplasms after chimeric antigen receptor T-cell therapy, but questions on causality remain given prior cytotoxic treatments received by patients receiving CAR T

Click this link to access over 200+ Aptitude Health business intelligence reports: https://www.aptitudehealth.com/oncology-reports/
Identify, understand, and respond to dynamics that shape clinical decision-making with real-world data sourced from scientific interchange on and disease topics, including the latest data from and .

Q2 2024 and reflect numerous advances and expanded indications for agents in a range of tumor types and molecular targets

New FDA and EMA Oncology Drug Approvals in Q2 2024 Largely Focused on Biologics and Specific Molecular Targets - Aptitude Health Aptitude Health’s quarterly recap of FDA- and EMA-approved oncology agents for 2024: A large proportion of approvals included biologics and new molecular targets in Q2

expert Enriqueta Felip, MD, PhD, shares her perspective on the latest advances and areas of opportunity in

Expert Perspectives in Management of NSCLC: A Conversation With Enriqueta Felip, MD, PhD - Aptitude Health Dr Enriqueta Felip of the Vall d’Hebron University Hospital in Barcelona, Spain, shares insights on treatment of patients with lung cancer

Happy Independence Day! Today, we celebrate the spirit of freedom and unity that defines the USA. Wishing everyone a joyful celebration!

Access our EPICS conference coverage reports: https://www.aptitudehealth.com/reports/. Adjacent to , we conducted expert meetings providing strategic insights into changing treatment paradigms in hematologic malignancies.

Ready to make a difference in patient-centered cancer care? Our HOLI clinical immersion programs improve your team’s disease-state knowledge. Contact us to get started: https://www.aptitudehealth.com/contact-us/

Contact Us - Aptitude Health Contact us to see how we can work together to transform your innovation into better outcomes.

The ONCOBOARD online platform provides life science companies rapid insights for key strategic questions from industry-recognized and experts or community physicians. Contact us to learn more:
https://www.aptitudehealth.com/contact-us/

Our Global Multiple Myeloma Academy empowers world-class education for oncologists and hematologists. To show your commitment to advancements in , become a sponsor of these well-attended virtual programs: https://globalmmacademy.com/become-a-sponsor/

Today marks , a day to honor freedom and reflect on the end of slavery in the United States in 1865.

Most drugs did not demonstrate overall survival or quality-of-life benefits within 5 years of receiving ​

Confirmation of Clinical Benefits and Regulatory Outcomes Following Accelerated Approval - Aptitude Health Clinical benefits and regulatory outcomes of cancer drugs receiving accelerated approval are not always substantiated by post-approval clinical trials

Connect with leading experts in care at the Global Leukemia Academy's upcoming virtual webinar focused on Latin America. Secure your spot today: https://globalleukemiaacademy.com/meeting-20/

This is why leading oncologists like Jeffrey S. Weber, MD, PhD, Professor of Medicine​ at NYU School of Medicine, appreciate being a member of the Axess Network. You can join too! Learn more and sign up today:
https://www.aptitudehealth.com/hcps/

New vaccination guideline issued for adults with to enhance cancer-related outcomes by reducing infection-related complications​

ASCO Vaccination Guideline Issued for Optimizing Vaccination Status Among Patients With Cancer - Aptitude Health New ASCO vaccination guideline issued for treatment of patients with cancer, including recommendations for those with solid tumors or hematologic malignancies

Attend the Global Leukemia Academy's virtual webinar for a thorough overview of acute leukemia treatments, with a focus on the LATAM treatment landscape. Free for HCPs. Register here: https://globalleukemiaacademy.com/meeting-20/

Our CASES reports on prostate cancer provide region-specific insights from US oncologists and urologists on management of nmCRPC and mCSPC. To view the agenda and download a sample report: https://www.aptitudehealth.com/oncology-reports/2024-cases-prostate-cancer/

Free for HCPs! Deepen your understanding of acute treatments. Join the next Global Leukemia Academy's webinar, featuring expert-led case-based discussions. Register now: https://globalleukemiaacademy.com/meeting-20/